Descriptive combination

COMBINATION PROFILE

bpc-kpv

Sources checked · October 16, 2026

Published for review · Scientific, medical, translation and citation review pending. Reported uses are not authorized indications. Frequency reflects mentions in supplied sources, not sales or global clinical prevalence.

Components

Community claim

Gut repair and inflammation claims.

Community and market provenance

Community mention, not clinical evidence

    Evidence of the exact combination

    No controlled clinical validation of this exact marketed combination was established in this review. Ingredient evidence is not combination evidence.

    Component links are not combination evidence. A commercial name’s composition may vary.

    Uncertainty and risks

    Mechanistic plausibility and animal findings do not establish human combination efficacy.

    Observed in supplier/community material; prevalence not quantified.

    No dosing or mixing instructions are provided.

    Source issues and references

    References include queries and bibliographic handbook attributions; not all are clinical studies. Human review remains pending.

    1. PMID18061177

      PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation.

      Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, Yan Y, Sitaraman S, Merlin D.

      October 16, 2026

    2. PMID36588717

      Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs.

      He L, Feng D, Guo H, Zhou Y, Li Z, Zhang K, Zhang W, Wang S, Wang Z, Hao Q, Zhang C, Gao Y, Gu J, Zhang Y, Li W, Li M.

      October 16, 2026

    3. R01

      FDA: BPC-157 evaluation, July 2026

    4. R02

      FDA: KPV evaluation, July 2026

    5. R07

      Lee and Burgess: intravenous BPC-157 pilot, 2025

    6. R08

      Intra-articular BPC-157 for knee pain, 2021

    7. R09

      Chang et al.: BPC-157 tendon fibroblast experiments, 2011

    8. R14

      Dalmasso et al.: PepT1-mediated KPV uptake, 2008

    A community-based bilingual scientific education initiative for healthcare professionals and the general public across the Americas.Currently self-funded; no current sponsors. Formal governance and legal documentation pending.info@peptideamericas.org · Planned contact address — not active yet; please do not send messages.